Scope and Opportunities Analysis of the Intraoperative Neuromonitoring (IONM) Market 2020-2030

Global Intraoperative Neuromonitoring Market: Overview

The global intraoperative neuromonitoring (IONM) market is expected to grow at a CAGR of 7.0% during the forecast period from 2014 to 2022 and gain a valuation of US$4,900 million by 2022.

Download PDF brochure:

Intraoperative neuromonitoring (IONM) is also known as intraoperative neurophysiological monitoring. The technology helps reduce the possibilities of neurological problems after or during surgeries involving the nervous system. Intraoperative neuromonitoring (IONM) systems use recordings of potentials such as EMG, EEG, and suggested potentials from the nervous system throughout a surgical procedure.

There has been an increase in the use of Intraoperative Neuromonitoring (IONM) systems during various surgical procedures due to the ability of these systems to help detect any injury before the severity of that injury leads to complications. postoperative in patients. Therefore, the use of intraoperative neuromonitoring (IONM) decreases the risk of patients experiencing health problems including paralysis, muscle weakness, hearing loss, and many other regular bodily functions.

The global intraoperative neuromonitoring (IONM) market is expected to observe sales growth in the coming years owing to increasing prevalence of chronic health conditions, increasing elderly population, rising the application of intraoperative neuromonitoring (IONM) in a wide range of surgeries, and risk management using this technology in complicated surgeries.

The global intraoperative neuromonitoring (IONM) market may witness slow growth due to low understanding of IONM and lack of skilled professionals in many emerging economies. On the other hand, rising medical tourism trend across the globe is estimated to create business prospects in the intraoperative neuromonitoring (IONM) market during the forecast period.

Companies operating in the global intraoperative neuromonitoring (IONM) market are increasing their cash flow towards R&D activities to improve the quality of services they offer. Additionally, companies in the Intraoperative Neuromonitoring (IONM) market are expanding their businesses using strategic moves such as collaborations, partnerships, and joint ventures.

Intraoperative neuromonitoring (IONM) refers to a key technology used during surgical procedures. The use of IONM serves to provide additional information and helps maintain nerve integrity, brain function and neural pathways.

Intraoperative neuromonitoring is mainly used for a few medical specialties. These include neurosurgery, ENT surgery, emergency surgery, visceral surgery, cardiothoracic surgery, orthopedics, vascular surgery, and general surgery. The use of IONM helps reduce the risk of damage to neurophysiologically relevant nerve structures at the time of surgery or possible damage to nerve function as a result of poor patient positioning. Using targeted neurostimulation, nerve structures can be pinpointed and potential damage avoided using a surgical approach. This allows surgeons to focus on optimizing the procedure while maintaining function.

Before the development of equipment and techniques for IONM, interventionists performed a simple visual check to determine if the muscle in question had shrunk after neurostimulation. These methods have become obsolete and no longer meet the requirements of today’s operating room.

Today, intraoperative neuromonitoring mainly involves two methods: continuous monitoring and localization neuromonitoring. Continuous monitoring involves clinicians monitoring tabular patient data in real time to observe changes in data morphology. Continuous monitoring includes EMG, AEP, EEG, SEP, MEP and VEP modalities.

On the other hand, neuromonitoring for localization involves the use of targeted stimulation that allows the surgeon to locate critical nerve structures in the area of ​​surgery. Thanks to this, surgeons have better spatial orientation and use targeted neurostimulation.

Intraoperative neuromonitoring is gaining ground in reducing the incidence of stroke and paralysis in major vascular procedures.

Global Intraoperative Neuromonitoring (IONM) Market: Overview

Due to the increasing focus on patient safety, the demand for intraoperative neuromonitoring has continued to increase at a rapid pace. The burden of healthcare costs on patients and their desire to avoid readmission have boosted the adoption of intraoperative neuromonitoring worldwide. Intraoperative neurophysiological monitoring (IONM) uses electrophysiological techniques such as electromyography (EMG), electroencephalography (EEG) and evoked potentials to effectively monitor the integrity of neural structures such as the spinal cord, nerves and certain parts of the brain. IONM is primarily conducted to provide functional guidance to surgeons in addition to reducing risk for patients with iatrogenic injuries.

Global Intraoperative Neuromonitoring (IONM) Market: Key Trends

According to the findings of the World Health Organization (WHO), nearly 80% of disorders leading to disabling conditions are neurological. Intraoperative monitoring has therefore become imperative in neurosurgery as it provides an early warning regarding sensory and motor functions during surgery. It has therefore enabled surgeons to obtain better results by eliminating postoperative neurophysiological deficits. Safer surgery therefore leads to a reduction in risk and procedure time. Due to these benefits, the demand for intraoperative neuromonitoring has grown exponentially in the healthcare industry.

This coupled with a favorable reimbursement scenario, especially in developed countries, increases the market outlook for the future. Market players are also focusing on strategic collaborations to expand their footprint and come up with innovations. These calculated steps observed in the Global Intraoperative Neuromonitoring Market will act in favor of its growth in the forthcoming years.

Global Intraoperative Neuromonitoring (IONM) Market: Market Potential

Recently, SpecialtyCare, recognized as a leading provider of surgical, infusion and intraoperative neuromonitoring services, acquired Sentient, a leading IONM provider in October 2016. Through this transaction, SpecialtyCare was able to extend its leadership as as one of the most comprehensive patient-centric outsourced IONM providers. services to hospitals, surgeons, health systems and surgery centers.

Following the acquisition, SpecialtyCare increased the total number of intraoperative neuromonitoring associates to support cases in the United States, which is also its current market, in addition to expanding coverage in Atlantic states. . These mergers and acquisitions will have a positive impact on the market by allowing it to expand its distribution network in markets yet to be explored. Key players in the global intraoperative neuromonitoring market are also looking to expand their strategic collaboration with their counterparts in emerging countries to expand their global footprint.

Global Intraoperative Neuromonitoring (IONM) Market: Regional Outlook

Regionally, the opportunities witnessed in the North America intraoperative neuromonitoring market are highly lucrative. In addition, considerable growth potential also exists for the market in Europe. Considering the improving reimbursement scenario in North America and Europe, these regions are also expected to remain at the forefront of the global market in the coming years. Additionally, the majority of developed countries have clearly defined procedures and codes for patients and insurance companies, which has made reimbursement processes easier and more convenient. These well-defined guidelines have yielded better results, thereby benefiting hospitals and patients and in turn accelerating the pace of gains for the intraoperative neuromonitoring market.

A large number of neurological centers in the United States recommend the use of intraoperative neuromonitoring in order to fill the shortage of manpower and meet the growing demand. Hospitals encourage physicians in addition to doctoral-level IONM providers to train and be certified by institutions such as the American Board of Nuclear Medicine. As the healthcare system strives to encourage the use of IONM, its demand is expected to increase further in the coming years. Additionally, the market is predicted to witness growing opportunities in Asia Pacific in the near future.

Global Intraoperative Neuromonitoring (IONM) Market: Competitive Landscape

Some of the prominent companies operating in the global intraoperative neuromonitoring market are Biotronic NeuroNetwork, Natus Medical Incorporated, SpecialtyCare, NeuroMonitoring Technologies, LLC, Accurate Monitoring, Medtronic, Sentient Medical Systems, and NuVasive Inc.

Download the complete table of contents:

About Us:

TMR Research is a leading provider of custom market research and advisory services to business entities seeking to succeed in today’s hectic economic climate. Backed by a team of experienced, dedicated and dynamic analysts, we redefine the way our clients do business by providing them with authoritative and reliable research studies, in line with the latest methodologies and market trends.

Contact us:

Rohit Bhisey

Internet Marketing Manager

Tel: +1-415-520-1050


Comments are closed.